Article: NEW JAPAN PEPTIDE VACCINE HOLDS PROMISE AGAINST VIRUSES, CANCER.

TOKYO, Feb 9 Asia Pulse - The National Institute of Infectious Diseases in conjunction with NOF Corp. (TSE:4403) has developed a promising new kind of peptide vaccine technology to fight cancers and viral infections.

Peptides are short fragments of proteins, and peptide vaccines use these instead of entire cell-surface proteins as antigens to help the body generate an immune response. The thinking is that even though viruses rapidly mutate, certain parts of their cell-surface proteins remain unchanged. A vaccine that is based on this kind of constant factor could provide broader immunity.

But because foreign peptides are quickly degraded and expelled by ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!